Related Articles
Baseline lymphopenia as prognostic factor in patients with metastatic breast cancer treated with palbociclib
Outcome of patients with glioblastoma in Saudi Arabia: Single center experience
Palbociclib added to ongoing endocrine therapy for hormone receptor‑positive HER2‑negative metastatic breast cancer: A case report series
Mortality and morbidity of curative and palliative anticancer treatments during the COVID‑19 pandemic: A multicenter population‑based retrospective study
Progression‑free survival of first‑line treatment with molecular‑targeted therapy may be a meaningful intermediate endpoint for overall survival in patients with metastatic renal cell carcinoma